Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)
Part of paid clinical trials in Stuart, Florida.
- Sponsor
- RPCR, Inc.
- Study ID
- NCT04985032
- Status
- Recruiting
Conditions
- Ductal Carcinoma in Situ
- Invasive Ductal Carcinoma of Female Breast
Eligibility Criteria
- Sex
- FEMALE
- Age
- 50 Years - 100 Years
- Healthy Volunteers
- Accepted
Interventions
- stereotactic body radiation therapy — RADIATIONTreatment technique used to deliver a highly focused and accurate radiation dose to a defined target volume outside the brain; the entire course of therapy delivered in five fractions or less
Study Details
This is a multi-institutional, prospective, observational registry investigating the safety and efficacy of Accelerated Partial Breast Irradiation (APBI) using a Stereotactic Body Radiation Therapy (SBRT) delivery technique that incorporates real-time image guidance, noncoplanar fields, and respiratory tracking. The study will accrue 200 patients who will be treated to a dose of 30 Gy over the course of 5 fractions. These subjects will then have a follow up time of 5 years
Key Dates
- Start date
- Aug 15, 2022
- Status verified
- Aug 2022
- Primary completion
- Aug 15, 2024
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 200 participants (estimated)
Primary Outcome Measure
Breast Cosmesis as measured by NRG-Radiation Therapy Oncology Group (RTOG) global cosmetic score (GCS) and the Harvard Cosmesis Scale (HCS) [ Time Frame: 2-3 years ]
Central Contacts
- Mark Perman, MD772-293-0377
- Debra Freeman, MD239-262-5168
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| CyberKnife Center of South Florida in Stuart | Stuart | Florida | 33996 | Mark Perman, MD 772-403-2390 Mark Perman, MD (PRINCIPAL_INVESTIGATOR) |
| CyberKnife Centers of Tampa Bay | Tampa | Florida | 33615 | Debra Freeman, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Stuart, FL
Related Studies
- DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Berkeley, California
- Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)PHASE2 · Recruiting · University of Florida · Gainesville, Florida
- Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisionsRecruiting · University of Florida · Gainesville, Florida
- Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In SituRecruiting · Glendale Adventist Medical Center d/b/a Adventist Health Glendale · Glendale, California